Revvity, Inc. (RVTY) Net Profit Margin: 8.30%
Is Revvity, Inc.’s net profit margin high or low?
Revvity, Inc.'s net profit margin of 8.30% is 34% below its 5-year average of 12.66%, around the middle of its 5-year range (-4.30%–24.64%).
As of Wednesday, June 17, 2026. 13.54% below its 12-month average of 9.60%.
RVTY Net Profit Margin Chart
RVTY Average Net Profit Margin Chart
RVTY Current vs Average Net Profit Margin Chart
RVTY Net Profit Margin Metrics
NET PROFIT MARGIN
8.30%
NET PROFIT MARGIN AVG TTM
9.60%
NET PROFIT MARGIN AVG 3Y
8.02%
NET PROFIT MARGIN AVG 5Y
12.66%
NET PROFIT MARGIN AVG 10Y
10.78%
NET PROFIT MARGIN AVG 15Y
8.95%
NET PROFIT MARGIN AVG 20Y
7.63%
CURRENT VS TTM AVG
-13.54%
CURRENT VS 3Y AVG
+3.46%
CURRENT VS 5Y AVG
-34.46%
CURRENT VS 10Y AVG
-23.03%
CURRENT VS 15Y AVG
-7.29%
CURRENT VS 20Y AVG
+8.72%
RVTY Competitors' Net Profit Margin
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Revvity, Inc. (RVTY) | $10.91B | 8.30% | 9.60% | 8.02% | 12.66% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -4.07% | -4.03% | -0.72% | 0.14% |
| Baxter International Inc. (BAX)vs › | $10.19B | -9.70% | -7.30% | -3.29% | 1.14% |
| The Cooper Companies, Inc. (COO)vs › | $12.69B | 5.57% | 9.62% | 9.77% | 24.94% |
| Align Technology, Inc. (ALGN)vs › | $12.86B | 10.50% | 10.36% | 10.48% | 22.21% |
| Solventum Corporation (SOLV)vs › | $12.91B | 17.33% | 12.25% | 14.36% | 15.15% |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.90B | -4.59% | -1.67% | 5.09% | 7.31% |
| Medpace Holdings, Inc. (MEDP)vs › | $13.05B | 17.19% | 18.50% | 17.20% | 16.74% |
| Tempus AI, Inc. (TEM)vs › | $8.51B | -22.20% | -60.53% | -62.93% | -77.31% |
| DaVita Inc. (DVA)vs › | $13.46B | 5.65% | 6.39% | 5.83% | 6.41% |
Margin Comparison
Operating Margin
12.4%
Net Profit Margin
8.3%
Revvity, Inc. Net Profit Margin Formula & Definition
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Revvity, Inc. Net Profit Margin FAQ
- What is the net profit margin for Revvity, Inc. (RVTY)?
- The net profit margin for RVTY stock is 8.30%.
- Is Revvity, Inc.'s net profit margin high or low?
- Revvity, Inc.'s net profit margin of 8.30% is 34% below its 5-year average of 12.66%, around the middle of its 5-year range (-4.30%–24.64%).
- What is the TTM average net profit margin for Revvity, Inc. (RVTY)?
- The TTM average net profit margin for RVTY stock is 9.60%.
- What is the 3Y average net profit margin for Revvity, Inc. (RVTY)?
- The 3Y average net profit margin for RVTY stock is 8.02%.
- What is the 5Y average net profit margin for Revvity, Inc. (RVTY)?
- The 5Y average net profit margin for RVTY stock is 12.66%.
- What is the 10Y average net profit margin for Revvity, Inc. (RVTY)?
- The 10Y average net profit margin for RVTY stock is 10.78%.
- What is the 15Y average net profit margin for Revvity, Inc. (RVTY)?
- The 15Y average net profit margin for RVTY stock is 8.95%.
- What is the 20Y average net profit margin for Revvity, Inc. (RVTY)?
- The 20Y average net profit margin for RVTY stock is 7.63%.
Revvity, Inc. Net Profit Margin History
| DATE | NET PROFIT MARGIN |
|---|---|
| 2025-12-28 | 8.46% |
| 2024-12-29 | 10.74% |
| 2023-12-31 | -4.30% |
| 2022-12-31 | 17.19% |
| 2021-12-31 | 24.64% |
| 2020-12-31 | 19.25% |
| 2019-12-31 | 7.89% |
| 2018-12-31 | 8.60% |
| 2017-12-31 | 5.01% |
| 2016-12-31 | 11.05% |
| 2015-12-31 | 10.09% |
| 2014-12-31 | 7.06% |
| 2013-12-31 | 7.75% |
| 2012-12-31 | 3.24% |
| 2011-12-31 | 0.06% |
| 2010-12-31 | 22.53% |
| 2009-12-31 | 5.52% |
| 2008-12-31 | 6.55% |
| 2007-12-31 | 7.44% |
| 2006-12-31 | 7.58% |
| 2005-12-31 | 5.55% |
| 2004-12-31 | 5.31% |
| 2003-12-31 | 3.45% |
| 2002-12-31 | -0.27% |
| 2001-12-31 | -0.05% |
| 2000-12-31 | 5.34% |
| 1999-12-31 | 2.08% |
| 1998-12-31 | 7.24% |
| 1997-12-31 | 2.31% |
| 1996-12-31 | 4.22% |
Related Metrics
About Revvity, Inc.
Revvity, Inc., founded in 1937 and based in Waltham, Massachusetts, is a global enterprise that develops and delivers a wide array of products, services, and solutions. The company, which changed its name from PerkinElmer, Inc. in April 2023, caters to the diagnostics, life sciences, and applied services sectors worldwide. Its Discovery & Analytical Solutions division provides advanced instrumentation, reagents, informatics, software, subscriptions, and sophisticated detection and imaging technologies. These resources are designed to enable scientists to achieve significant breakthroughs in life sciences research. This segment also offers contract research and specialized laboratory services. Furthermore, it supplies analytical tools and services for assessing environmental health, including air, water, and soil, and delivers solutions to agricultural and food producers. It also serves the industrial market with analytical instrumentation for sectors such as chemical, semiconductor, electronics, energy, lubricants, petrochemicals, and polymers. The Diagnostics segment is dedicated to early detection, offering instruments, reagents, assay platforms, and software for identifying genetic disorders in pregnant individuals and young children, alongside infectious disease testing. Its products facilitate the screening of genetic abnormalities, disorders, and diseases like Down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This division also innovates technologies that support genomic workflows, leveraging protein-coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. Revvity serves a diverse clientele, including pharmaceutical and biotechnology firms, laboratories, academic and research institutions, public health authorities, private healthcare organizations, medical professionals, and government bodies.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Prahlad R. Singh